Polynovo share price sinks lower despite doubling sales in FY 2020

The Polynovo Ltd (ASX:PNV) share price is dropping notably lower on Wednesday despite doubling its sales in FY 2020…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Polynovo Ltd (ASX: PNV) share price has been among the worst performers on the S&P/ASX 200 Index (ASX: XJO) on Wednesday following the release of its full year results for FY 2020.

In afternoon trade the dermal regeneration solutions-focused medical device company's shares are down 8.5% to $2.16.

How did PolyNovo perform in FY 2020?

PolyNovo had a very positive 12 months and delivered strong NovoSorb BTM sales growth in FY 2020.

For the 12 months ended 30 June 2020, the company sales revenue grew 104% to $19.1 million.

This was driven by strong growth in all markets, but particularly in the United States. The company's US business delivered a record quarterly sales result in the March quarter and then followed it up with a 36% increase in sales compared to the prior corresponding period during the June quarter.

Management notes that it is building a solid revenue base in trauma, reconstructive surgery, hand surgery, necrotising fasciitis, and general surgery. Its Burn sales are also strong, with significant account penetration in accredited burn centres in all regions

However, also growing strongly during the year was the company's operating expenses. They increased 28.4% year on year to $22.6 million.

As a result, the company posted an operating loss of $1.1 million, down from FY 2019's operating loss of $2.8 million. And on the bottom line, it reported a net loss after tax of $4.2 million. While this compares unfavourably to a net loss of $3.2 million a year earlier, it includes $2.06 million in share-based payments.

In respect to cash flow, PolyNovo reported a net cash outflow from operations of $0.4 million, leaving it with a cash balance of $11.6 million.

Outlook.

Management notes that there has been no material impact on its business from the COVID-19 pandemic. It revealed that its global digital marketing program is proving effective and sales continue to grow.

And while no guidance was given for the year ahead, management revealed that its fourth quarter sales came in at $5.99 million. This means PolyNovo starts FY 2021 with a sales run rate of $24 million, which already implies annual growth of almost 26%.

It also advised that it plans to reinvest its cashflows back into the business. It aims to use the funds to enter new markets, expand its market share, and develop new products.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A worried man holds his head and look at his computer.
Share Fallers

Why 29Metals, Brainchip, Platinum, and Premier Investments shares are falling today

These ASX shares are having a tough time on hump day.

Read more »

Man with his head in his head because of falling share price.
Share Fallers

Why 29Metals, Atlas Arteria, IDP Education, and Mineral Resources shares are falling

These ASX shares are having a tough time on Tuesday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why ALS, EOS, NRW, and Patriot Battery Metals are dropping today

These ASX shares are starting the week in the red.

Read more »

A man looking at his laptop and thinking.
Technology Shares

Why are these ASX tech shares getting smashed today?

Owners of these two stocks are missing out today.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why AGL, Brickworks, IGO, and New Hope shares are dropping today

These ASX shares are having a poor session. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Amcor, Arafura, Brainchip, and South32 shares are tumbling today

These ASX shares are having a tough time on hump day. But why?

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Share Fallers

Why Aussie Broadband, Liontown, Metals Acquisition, and Seek shares are falling

These ASX shares are having a poor session. But why?

Read more »